Copyright
©2009 The WJG Press and Baishideng.
World J Gastroenterol. Oct 28, 2009; 15(40): 5020-5027
Published online Oct 28, 2009. doi: 10.3748/wjg.15.5020
Published online Oct 28, 2009. doi: 10.3748/wjg.15.5020
Figure 2 Hepatitis C RNA titers relative to HMG-coA reductase inhibitor exposure.
Log HCV RNA viral load (IU/mL) in Group A, Group B, and Group C subjects. A: Entire cohort; B: Genotype 1 patients; C: Genotype 2 patients; D: Patients in which genotype was not available. Box plots indicate median, 25th and 75th percentiles (box), and 5th and 95th percentiles. P-value obtained by Kruskal-Wallis test.
- Citation: Forde KA, Law C, O’Flynn R, Kaplan DE. Do statins reduce hepatitis C RNA titers during routine clinical use? World J Gastroenterol 2009; 15(40): 5020-5027
- URL: https://www.wjgnet.com/1007-9327/full/v15/i40/5020.htm
- DOI: https://dx.doi.org/10.3748/wjg.15.5020